Cancer patients' lymphocytes contain CD3+ CD4+ cells that proliferate in response to autologous tumor cells in the presence of exogenous low-dose interleukin-2 and autologous accessory cells.

Radrizzani, M

Cancer patients' lymphocytes contain CD3+ CD4+ cells that proliferate in response to autologous tumor cells in the presence of exogenous low-dose interleukin-2 and autologous accessory cells. [electronic resource] - Cancer immunology, immunotherapy : CII 1989 - 233-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0340-7004

10.1007/BF01665010 doi


Antigen-Presenting Cells--physiology
Antigens, CD--analysis
Antigens, Differentiation, T-Lymphocyte--analysis
CD3 Complex
CD4 Antigens--analysis
CD4-Positive T-Lymphocytes--immunology
Humans
Interleukin-2--pharmacology
Lymphocyte Activation
Neoplasms--immunology
Phenotype
Receptors, Antigen, T-Cell--analysis
T-Lymphocytes--immunology